Revenue
$11.34B
Fiscal year ended 2026-07-31Operating income
$2.33B
Fiscal year ended 2026-07-31Free cash flow
$1.10B
Fiscal year ended 2026-07-31Salesforce, Inc. (CRM) reported revenue of $11.34B and net income of $3.53B for the fiscal year ended 2026-07-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Salesforce, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Prepackaged Software.
Income
| Metric | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.34B | $11.13B | $11.20B | $10.26B | $10.24B | $9.83B | $9.99B | $9.44B | $9.32B | $9.13B |
| Cost of revenue | $2.65B | $2.57B | $2.51B | $2.26B | $2.24B | $2.26B | $2.22B | $2.10B | $2.16B | $2.16B |
| Gross profit | $8.70B | $8.56B | $8.69B | $8.00B | $7.99B | $7.56B | $7.78B | $7.34B | $7.17B | $6.97B |
| Operating income | $2.33B | $2.35B | $1.87B | $2.19B | $2.33B | $1.94B | $1.82B | $1.89B | $1.78B | $1.71B |
| Net income | $3.53B | $2.11B | $1.94B | $2.09B | $1.89B | $1.54B | $1.71B | $1.53B | $1.43B | $1.53B |
| Research & development | $1.69B | $1.63B | $1.62B | $1.43B | $1.48B | $1.46B | $1.42B | $1.36B | $1.35B | $1.37B |
| Weighted-average diluted shares | shares 821.00M | shares 871.00M | Unavailable | shares 952.00M | shares 962.00M | shares 970.00M | Unavailable | shares 965.00M | shares 973.00M | shares 985.00M |
| Pretax income | $4.55B | $2.72B | $2.63B | $2.51B | $2.41B | $1.97B | $1.99B | $1.75B | $1.84B | $1.87B |
| Income tax expense | $1.03B | $614.00M | $685.00M | $426.00M | $519.00M | $433.00M | $280.00M | $219.00M | $408.00M | $334.00M |
| Diluted EPS | $4.29 | $2.42 | Unavailable | $2.19 | $1.96 | $1.59 | Unavailable | $1.58 | $1.47 | $1.56 |
| Selling, general & administrative | $4.58B | $4.51B | $4.92B | $4.12B | $4.18B | $4.13B | $4.24B | $4.03B | $3.94B | $3.89B |
| General & administrative | $725.00M | $740.00M | $902.00M | $667.00M | $734.00M | $697.00M | $767.00M | $711.00M | $711.00M | $647.00M |
| Selling & marketing | $3.86B | $3.77B | $4.02B | $3.46B | $3.44B | $3.43B | $3.47B | $3.32B | $3.22B | $3.24B |
Balance
| Metric | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8.31B | $8.94B | $7.33B | $8.98B | $10.36B | $10.93B | $8.85B | $8.00B | $7.68B | $9.96B |
| Total assets | $109.62B | $106.68B | $112.30B | $95.14B | $97.57B | $98.61B | $102.93B | $91.40B | $92.18B | $96.18B |
| Current assets | $22.08B | $21.61B | $28.22B | $21.06B | $25.33B | $25.87B | $29.73B | $21.42B | $21.86B | $25.60B |
| Total liabilities | $71.24B | $72.44B | $53.16B | $35.12B | $36.24B | $37.94B | $41.76B | $32.87B | $34.55B | $36.50B |
| Current liabilities | $26.34B | $27.50B | $37.12B | $21.41B | $22.53B | $24.20B | $27.98B | $19.38B | $21.00B | $23.15B |
| Total equity incl. NCI | $38.38B | $34.24B | $59.14B | $60.02B | $61.33B | $60.67B | $61.17B | $58.52B | $57.63B | $59.68B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $6.32B | $5.08B | $14.34B | $5.47B | $5.60B | $4.35B | $11.94B | $4.74B | $5.39B | $4.27B |
| Goodwill | $59.25B | $59.29B | $57.94B | $52.46B | $51.44B | $51.28B | $51.28B | $49.09B | $48.94B | $48.94B |
| Long-term debt | $39.29B | $39.28B | $10.44B | $8.44B | $8.44B | $8.44B | $8.43B | $8.43B | $8.43B | $8.43B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.27B | $6.70B | $5.46B | $2.32B | $740.00M | $6.48B | $3.97B | $1.98B | $892.00M | $6.25B |
| Capital expenditures | $171.00M | $145.00M | $141.00M | $139.00M | $135.00M | $179.00M | $154.00M | $204.00M | $137.00M | $163.00M |
| Investing cash flow | -$1.20B | -$2.18B | -$8.71B | $519.00M | $1.16B | -$1.57B | -$2.94B | -$217.00M | $2.64B | -$2.65B |
| Financing cash flow | -$622.00M | -$2.92B | $1.59B | -$4.24B | -$2.50B | -$2.92B | -$73.00M | -$1.45B | -$5.80B | -$2.11B |
| Net change in cash | -$625.00M | $1.61B | -$1.65B | -$1.39B | -$563.00M | $2.08B | $851.00M | $315.00M | -$2.28B | $1.49B |
| Stock-based compensation | $906.00M | $857.00M | $1.08B | $819.00M | $793.00M | $814.00M | $803.00M | $820.00M | $810.00M | $750.00M |
| Common dividends paid | $364.00M | $365.00M | $391.00M | $395.00M | $399.00M | $402.00M | $383.00M | $382.00M | $384.00M | $388.00M |
| Common share repurchases | $84.00M | $27.25B | $3.94B | $3.80B | $2.22B | $2.63B | $76.00M | $1.28B | $4.34B | $2.13B |
| Depreciation & amortization | $966.00M | $985.00M | $1.12B | $851.00M | $817.00M | $843.00M | $877.00M | $814.00M | $907.00M | $879.00M |
Derived
| Metric | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $1.10B | $6.56B | $5.32B | $2.18B | $605.00M | $6.30B | $3.82B | $1.78B | $755.00M | $6.08B |
| Gross margin | 76.7% | 76.9% | 77.6% | 78.0% | 78.1% | 77.0% | 77.8% | 77.7% | 76.8% | 76.3% |
| Operating margin | 20.5% | 21.1% | 16.7% | 21.3% | 22.8% | 19.8% | 18.2% | 20.0% | 19.1% | 18.7% |
| FCF margin | 9.7% | 58.9% | 47.5% | 21.2% | 5.9% | 64.1% | 38.2% | 18.8% | 8.1% | 66.6% |
| SBC / revenue | 8.0% | 7.7% | 9.7% | 8.0% | 7.7% | 8.3% | 8.0% | 8.7% | 8.7% | 8.2% |
| Current ratio | 0.84x | 0.79x | 0.76x | 0.98x | 1.12x | 1.07x | 1.06x | 1.11x | 1.04x | 1.11x |
| Revenue YoY growth | 10.8% | 13.3% | 12.1% | 8.6% | 9.8% | 7.6% | 7.6% | 8.3% | 8.4% | 10.7% |
| Net margin | 31.1% | Unavailable | 17.3% | 20.3% | 18.4% | Unavailable | 17.1% | 16.2% | Unavailable | Unavailable |
| R&D / revenue | 14.9% | 14.6% | 14.5% | 14.0% | 14.5% | 14.9% | 14.2% | 14.4% | 14.5% | 15.0% |
| CapEx / revenue | 1.5% | 1.3% | 1.3% | 1.4% | 1.3% | 1.8% | 1.5% | 2.2% | 1.5% | 1.8% |
| Long-term debt / equity | 1.02x | Unavailable | 0.18x | 0.14x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 22.5% | 22.6% | 26.1% | 17.0% | 21.6% | 21.9% | 14.1% | 12.5% | 22.2% | 17.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CRM in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-27View SEC filing
10-Q · Filed 2026-05-28View SEC filing
10-K · Filed 2026-03-02View SEC filing
10-Q · Filed 2025-12-04View SEC filing
10-Q · Filed 2025-09-04View SEC filing
10-Q · Filed 2025-05-29View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.